Top

Published in:

01-02-2013 | Neurology and Preclinical Neurological Studies - CONy Pro/Con debate

Why antiplatelet treatment in spontaneous internal carotid dissection?

Authors: O. Bajenaru, C. Tiu, B. Dorobat, F. Antochi

Published in: Journal of Neural Transmission | Issue 2/2013

Abstract

Spontaneous dissection of the internal carotid artery is a leading cause of stroke and TIA, particularly in young patients. The antithrombotic treatment with or without an interventional procedure is a unanimously accepted indication for the prevention of the ischemic events in these patients. Whether anticoagulants or antiplatelets as antithrombotics are a better option is a matter of debate. The authors, based on clinical and pathophysiological data in the published studies and their own experience argue in favour of antiplatelets in most cases, without excluding the need of anticoagulants in some cases, due to the lack of objective proofs for the superiority of anticoagulants in this pathology and at the same time, a better safety profile of antiplatelets. To have a clear-cut answer to this debate, a large comparative randomized clinical trial between the two types of treatment is desirable.

Brandt T, Orberk E, Weber R, Werner I, Busse O, Müller BT, Wigger F, Grau A, Grond-Ginsbach C, Hausser I (2001) Pathogenesis of cervical artery dissections: association with connective tissue abnormalities. Neurology 57:24–30PubMedCrossRef

Coull BM, Williams LS, Goldstein LB, Meschia JF, Heitzman D, Chaturvedi S, Johnston KC, Starkman S, Morgenstern LB, Wilterdink JL, Levine SR, Saver JL (2002) Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association). Stroke 33:1934–1942PubMedCrossRef

Debette S, Leys D (2009) Cervical-artery dissections: predisposing factors, diagnosis, and outcome. Lancet Neurol 8:668–678PubMedCrossRef

Dreier JP, Lurtzing F, Kappmeier M, Bohner G, Klingebiel R, Leistner S, Einhaupl KM, Schielke E, Valdueza JM (2004) Delayed occlusion after internal carotid artery dissection under heparin. Cerebrovasc Dis 18:296–303PubMedCrossRef

Engelter ST, Brandt T, Debette S, Caso V, Lichy C, Pezzini A, Abboud S, Bersano A, Dittrich R, Grond-Ginsbach C, Hausser I, Kloss M, Grau AJ, Tatlisumak T, Leys D, Lyrer PA, for the Cervical Artery Dissection in Ischemic Stroke Patients (CADISP) Study Group (2007) Antiplatelets versus anticoagulation in cervical artery dissection. Stroke 38:2605–2611PubMedCrossRef

Fluri F, Lyrer PA, Steck AJ, Engelter ST (2007) Internal carotid artery dissection with occlusion during heparin therapy. Swiss Arch Neurol Psychol 158:331–333

Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC, Halperin JL, Johnston SC, Katzan I, Kernan WN, Mitchell PH, Ovbiagele B, Palesch YY, Sacco RL, Schwamm LH, Wassertheil-Smoller S, Turan TN, Wentworth D, American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Clinical Cardiology, Interdisciplinary Council on Quality of Care and Outcomes Research (2011) Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42:227–276PubMedCrossRef

Georgiadis D, Arnold M, von Buedingen HC, Valko P, Sarikaya H, Rousson V, Mattle HP, Bousser MG, Baumgartner RW (2009) Aspirin vs anticoagulation in carotid artery dissection: a study of 298 patients. Neurology 72:1810–1815PubMedCrossRef

International Stroke Trial Collaborative Group (1997) The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 349:1569–1581CrossRef

Jeon P, Kim BM, Kim DI, Shin YS, Kim KH, Park SI, Kim DJ, Suh SH (2010) Emergent self-expanding stent placement for acute intracranial or extracranial internal carotid artery dissection with significant hemodynamic insufficiency. Am J Neuroradiol 31:1529–1532PubMedCrossRef

Kadkhodayan Y, Jeck DT, Moran CJ, Derdeyn CP, Cross DT 3rd (2005) Angioplasty and stenting in carotid dissection with or without associated pseudoaneurysm. Am J Neuroradiol 26:2328–2335PubMed

Kennedy F, Lanfranconi S, Hicks C, Reid J, Gompertz P, Price C, Kerry S, Norris J, Markus HS, on behalf of the CADISS Investigators (2012) Antiplatelets vs anticoagulation for dissection: CADISS nonrandomized arm and meta-analysis. Neurology 79:686–689PubMedCrossRef

Lyrer Ph, Engelter S (2004) Antithrombotic drugs for carotid artery dissection. Stroke 35:613–614PubMedCrossRef

Lyrer P, Engelter S (2010) Antithrombotic drugs for carotid artery dissection. Cochrane Database Syst Rev 10:CD000255

Menon R, Kerry S, Norris JW, Markus HS (2008) Treatment of cervical artery dissection: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 79:1122–1127PubMedCrossRef

Patel RR, Adam R, Maldjian C, Lincoln CM, Yuen A, Arneja A (2012) Cervical carotid artery dissection: current review of diagnosis and treatment. Cardiol Rev 20:145–152PubMedCrossRef

Perren F, Bocquet L, Saulnier F, Landis T, Sztajzel R (2006) Does anticoagulation harm in acute cervical artery dissection? Cerebrovasc Dis 21(Suppl 4):146

Prabhakaran S, Khandji A, Wright CB (2006) Extracranial internal carotid artery dissection with unusual gadolinium enhancement. Neurology 67:536–537PubMedCrossRef

Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, Gorelick P, Halperin J, Harbaugh R, Johnston SC, Katzan I, Kelly-Hayes M, Kenton EJ, Marks M, Schwamm LH, Tomsick T, American Heart Association, American Stroke Association Council on Stroke, Council on Cardiovascular Radiology and Intervention, American Academy of Neurology (2006) Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 37:577–617PubMedCrossRef

Yaghi S, Maalouf N, Keyrouz SG (2012) Cervical artery dissection: risk factors, treatment, and outcome; a 5-year experience from a tertiary care center. Int J Neurosci 122:40–44PubMedCrossRef

Title: Why antiplatelet treatment in spontaneous internal carotid dissection?
Authors: O. Bajenaru
C. Tiu
B. Dorobat
F. Antochi
Publication date: 01-02-2013
Publisher: Springer Vienna
Published in: Journal of Neural Transmission / Issue 2/2013
Print ISSN: 0300-9564
Electronic ISSN: 1435-1463
DOI: https://doi.org/10.1007/s00702-012-0942-4

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Why antiplatelet treatment in spontaneous internal carotid dissection?

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2013

Association and CpG SNP analysis of HTR4 polymorphisms with suicidal behavior in subjects with schizophrenia

Evaluation of speech impairment in early stages of Parkinson’s disease: a prospective study with the role of pharmacotherapy

Anticoagulants versus antiplatelet drugs for cervical artery dissection: case for anticoagulants

Refractory epileptic seizures due to vitamin B6 deficiency in a patient with Parkinson’s disease under duodopa® therapy

AbobotulinumtoxinA (Dysport) dosing in cervical dystonia: an exploratory analysis of two large open-label extension studies

Immunogenicity of botulinum toxins